April 25, 1989 |
Swiss drug manufacturing giant F. Hoffmann-La Roche & Co. said Monday that it will modernize its share structure and reorganize its corporate framework. The changes would make it easier to invest in the company and conform to pending changes in Swiss corporate law. Hoffmann-La Roche failed in a takeover bid for Sterling Drug Inc. last year, and the streamlining could help the company in other U.S. takeover attempts, some analysts said. The company's U.S. operations, which accounted for $1.9 billion in revenue out of the parent's $6 billion, are based in Nutley, N.J. One school of thought holds that a global consolidation in the pharmaceutical business is inevitable.
April 20, 1993 |
Fifteen major U.S. and European pharmaceutical companies on Monday announced that they will share information from AIDS research efforts in an attempt to reduce drug-development time. After more than a year of formal discussions, the group, which includes Merck & Co., Pfizer Inc., Glaxo of Britain and Switzerland's Hoffman-La Roche, has agreed to exchange clinical data and drug supplies so that antiviral medicines can be tested in the best possible combinations.
June 22, 1995 |
The first of a promising but still experimental new class of AIDS drugs will be made available free to about 2,000 patients through a government-sanctioned lottery. Manufacturer Hoffman-La Roche will offer Invirase to patients in the advanced stages of AIDS who are not participating in clinical trials of the class of drugs known as protease inhibitors, which appear to be the most potent yet at reducing the amount of HIV virus in a patient's blood.
December 1, 2006 |
Drug company agents, who say they routinely work 60-hour weeks visiting doctors' offices, said Thursday that they had sued Pfizer Inc., Johnson & Johnson and six other drug companies for failing to pay overtime. The lawsuits, which could involve tens of thousands of U.S. employees, add the pharmaceutical industry to other sectors that have been accused of giving rank-and-file workers managerial-like job titles to avoid paying overtime.
March 23, 1997 |
During the first half of his semester in Africa last year, Matthew Nelson took his prescription antimalarial, mefloquine (Lariam) each week on schedule. But then the 20-year-old Pomona College student noticed some troublesome side effects and blamed them on the medicine. On Sundays, the day he took the medicine, he said he felt depressed. "I was having some stomach problems that I thought might be related," he said. Halfway through the school term, he stopped taking mefloquine and felt better.
July 27, 1995 |
Perhaps heralding a leaner future for an ever-fatter America, scientists have gotten genetically obese mice to lose a third of their weight in two weeks by injecting them with a newly discovered hormone that regulates body fat. Besides studying the grotesquely obese mice, the scientists, led by Jeffrey M. Friedman, a molecular geneticist at the Howard Hughes Medical Institute and the Rockefeller University, have found a nearly identical hormone in human beings.